Hem n Onc 8-5 (4) Flashcards
This child presents with a new viral upper respiratory infection (URI) and has a history of recurrent infections, conotruncal abnormality repair, and cleft lip/palate repair (surgical scar in image). He also has signs of hypocalcemia given the positive Chvostek sign on physical exam. Taken together, these findings suggest a diagnosis of DiGeorge syndrome.
DiGeorge syndrome is caused by a 22q11 chromosomal microdeletion that results in abnormal embryologic development of the 3rd and 4th branchial pouches. Use the mnemonic “CATCH-22” to remember the features of DiGeorge syndrome: Cleft palate, Abnormal facies, Thymic aplasia, Cardiac defects, and Hypocalcemia.
Because the thymus is normally derived from ?
the 3rd branchial pouch, children with DiGeorge syndrome can have a T-lymphocyte deficiency that predisposes them to recurrent viral and fungal infections (as seen in this patient).
The first pharyngeal arch has several derivatives, which can be remembered by thinking of the letter “M”:
Maxillary processes (Maxilla, zygoMatic bone)
Mandibular processes (Meckel cartilage, Mandible, Malleus and incus, sphenoMandibular ligament)
Muscles of Mastication (teMporalis, Masseter, lateral and Medial pterygoid)
Mylohyoid
Derivatives of the first branchial arch are innervated by ?
the V2 and V3 branches of cranial nerve V. When the neural crest cells of the first pharyngeal arch fail to migrate, patients may develop Treacher Collins syndrome. Although Treacher Collins syndrome can manifest with facial abnormalities (most commonly mandibular hypoplasia), the findings in this patient are not consistent with this syndrome.
The second branchial arch derivatives can be remembered by thinking of the letter “S”:
Stapes, Styloid process, Stylohyoid ligament
Muscles of facial expression (“Smile”)
Stapedius
Stylohyoid
PlatySma
The derivatives of the second arch are innervated by ?
Cranial nerve VII. The facial muscle twitching elicited in this patient by tapping the cheek (over the facial nerve) is called Chvostek sign and is associated with hypocalcemia. The second branchial arch is not involved in this patient’s condition.
The second, third, and fourth branchial clefts form temporary cervical sinuses that are obliterated before fetal maturation. Normally they have no derivatives in the adult, but a persistent cervical sinus can result in a branchial cleft cyst within the lateral neck. The third branchial cleft has no association with this patient’s underlying condition.
The fourth branchial pouch gives rise to the dorsal wings, which develop into the superior parathyroid glands. Failure of parathyroid development results in ?
hypocalcemia, which is evidenced in this patient by a positive Chvostek sign on physical exam (tapping the cheek causes contraction of the facial muscles). Although the fourth branchial pouch is involved in this patient’s underlying condition, this embryologic structure does not give rise to any immunologic cells or organs.
After an upper respiratory tract infection, this patient is experiencing persistent epistaxis, ecchymoses (including petechial hemorrhages seen in the image), and marked thrombocytopenia. However, his leukocyte count with differential, hematocrit, international normalized ratio (INR), and fibrinogen levels are within normal ranges. Therefore this patient’s history and laboratory test results suggest an isolated acquired thrombocytopenia caused by sequestration, destruction, and/or increased platelet consumption. Most likely the patient’s significant thrombocytopenia is a result of platelet destruction from?
idiopathic thrombocytopenic purpura (ITP), which is also known as immune thrombocytopenic purpura, an autoimmune disease most often triggered by a viral illness.
Idiopathic thrombocytopenic purpura (ITP) is immune mediated destruction of platelets, commonly occurring in ?
children weeks after an upper respiratory infection. It manifests as ecchymosis, petechiae, mucosal bleeding, and marked thrombocytopenia.
The finding of decreased megakaryocytes on bone marrow biopsy suggests a defect in platelet production, which may be the result of bone marrow malignancy, fibrosis, or aplastic anemia. Conditions such as these would produce abnormalities in the complete blood count (CBC).
Increased fibrin split products are a sign of activation of the coagulation cascade and are associated with thrombocytopenia when disseminated intravascular coagulation (DIC) occurs.
Conditions such as HUS, TTP, or DIC can cause?
schistocytes on peripheral blood smears when RBCs pass through fibrin strands and become sheared. These disorders have abnormalities in fibrinogen levels as well as the INR for DIC.
Vitamin K deficiency leads to decreased levels of clotting factors II, VII, IX, and X. This would result in a prolonged INR (prothrombin time).
This patient presents with recurrent diarrhea, flushing, and respiratory wheezes. Her CT scan shows a 6-cm mass near the ileocecal junction. The symptoms and the CT finding suggest a diagnosis of carcinoid syndrome, a rare disorder caused by excessive serotonin secretion by metastatic small bowel and appendiceal tumors.
Carcinoid syndrome is characterized by diarrhea, cutaneous flushing, asthmatic wheezing, and right-sided valvular disease. Symptoms generally do not occur until metastasis to or beyond the?
liver occurs (red circle indicates the ileocecal mass), as serotonin undergoes extensive first-pass metabolism in the liver. When a patient presents with nonbloody diarrhea and abdominal tenderness, a CT scan is ordered to see if a neoplasm may be the cause of such symptoms.
The other findings are not associated with this patient’s condition. Metastases of the ileocecal tumor to the lungs could potentially cause wheezing, but would not explain diarrhea and flushing. A VIP-secreting pancreatic mass (VIPoma) would lead to ?
diarrhea, dehydration, and hypokalemia, but would not explain the patient’s ileocecal mass, wheezing, or flushing.
Bowel obstruction would likely be apparent on CT scan of the abdomen; however, this patient is not experiencing symptoms consistent with obstruction. Metastasis to the brain (intracranial mass) would likely produce?
neurologic deficits, none of which are present in this patient.
A clinician reads a study on the diagnosis of iron deficiency anemia based on the presence of target cells in peripheral blood smears. The study was performed in a homogenous community in northern Europe. However, the clinician’s patient population is largely composed of people of African and Asian descent, populations that have an increased rate of hemoglobinopathies compared with northern Europeans. She is concerned that the predictive value of the test would be different if the study were reproduced using her patient population.
Which measure of quality does the study lack?
External validity
In this case the clinician is concerned about the lack of external validity, which is the extent to which study results are applicable to a population other than the study population. External validity may be decreased if the study population varies from other populations by characteristics that might lead to?
significantly different results. Randomization is one way to help ensure appropriate external validity.
External validity is a measure of accuracy, and lack of external validity leads to low accuracy. However, accuracy is not the correct answer to this question, because we don’t have enough data in the stem to evaluate its accuracy. Internal validity is a measure of ?
how well the study rules out alternative causes that could explain the results.
Confounding variables are always a concern for researchers; but given that the original study was performed in a homogenous population, the risk of confounding variables isn’t the clinician’s primary concern.
Reliability assesses the consistency and reproducibility of a study were it to be repeated in a similar population, but again, this clinician is worried how the study’s findings would apply?
to her patient population and not whether they could be reproduced in the population similar to that in the original study.
This 30-year-old woman presents with severe knee pain and a tender effusion on the knee. Based on the patient’s age and gender, as well as the location of the tumor, she most likely has a giant cell tumor. The appearance of the tumor—with a nonsclerotic and sharply defined border—is also a clue that this is a giant cell tumor.
Giant cell tumors are primary bone tumors that most commonly occur at ?
the epiphyseal end of long bones. They are benign, but locally aggressive tumors occurring most frequently at the distal femur or proximal tibia. Giant cell tumors have a peak incidence in people from age 20 to 40 years old. They tend to occur more often in women.